Skip to content

Clinical trials

Phase 2 Joint Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Joint Diseases Phase: Phase 2 Country / region: United States Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20051
20061
20101
20111
20132
20142
20161
20191
20201
20212
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie2
BioCryst Pharmaceuticals2
Celgene2
Cara Therapeutics, Inc.1
Eli Lilly and Company1
Icahn School of Medicine at Mount Sinai1
Institut de Recherches Internationales Servier1
MoonLake Immunotherapeutics AG1
National Center for Complementary and Integrative Health (NCCIH)1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Joint Diseases17
Arthritis13
Musculoskeletal Diseases7
Arthritis, Rheumatoid5
Osteoarthritis5
Rheumatic Diseases5
Autoimmune Diseases4
Immune System Diseases3
Connective Tissue Diseases2
Gout2

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.